Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities
Net income (loss)	$ 290	$ 257	$ (1,123)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Amortization of premiums and accretion of discounts associated with investments, net	(304)	(301)	(258)
(Gains) losses on investments, net	56	267	227
(Gains) losses on derivatives, net	(1,360)	1,456	2,632
(Income) loss from equity method investments, net of dividends and distributions	(25)	41	76
Interest credited to policyholder account balances	2,161	2,110	1,801
Universal life and investment-type product policy fees	(1,678)	(1,601)	(1,778)
Change in market risk benefits, net	203	(2,089)	(888)
Change in accrued investment income	145	(117)	(212)
Change in premiums, reinsurance and other receivables	(403)	(1,482)	(1,279)
Change in deferred policy acquisition costs and value of business acquired, net	98	113	155
Change in income tax	18	(8)	(380)
Change in other assets	1,094	1,116	1,100
Change in future policy benefits and other policy-related balances	(215)	(316)	(62)
Change in other liabilities	402	377	(18)
Net cash provided by (used in) operating activities	482	(177)	(7)
Cash flows from investing activities
Sales, maturities and repayments of fixed maturity securities	12,445	11,559	5,922
Sales, maturities and repayments of trading securities	44	0	0
Sales, maturities and repayments of equity securities	26	46	30
Sales, maturities and repayments of mortgage loans	2,541	1,518	1,206
Sales, maturities and repayments of limited partnerships and limited liability companies	570	337	205
Purchases of fixed maturity securities	(11,973)	(11,811)	(8,699)
Purchases of trading securities	(199)	0	0
Purchases of equity securities	(2)	(3)	(4)
Purchases of mortgage loans	(2,163)	(2,374)	(813)
Purchases of limited partnerships and limited liability companies	(278)	(299)	(453)
Cash received in connection with freestanding derivatives	16,795	12,453	5,048
Cash paid in connection with freestanding derivatives	(18,258)	(11,856)	(5,422)
Receipts on loans to affiliate	0	0	125
Net change in policy loans	578	(688)	(40)
Net change in short-term investments	513	(572)	(259)
Net change in other invested assets	21	(369)	(109)
Net cash provided by (used in) investing activities	660	(2,059)	(3,263)
Cash flows from financing activities
Policyholder account balances: Deposits	19,746	29,950	21,514
Policyholder account balances: Withdrawals	(20,899)	(26,287)	(17,641)
Net change in payables for collateral under securities loaned and other transactions	822	214	(887)
Long-term and short-term debt repaid	(2)	(2)	(127)
Dividends paid to parent	0	0	(266)
Capital contribution	100	0	0
Financing element on certain derivative instruments and other derivative related transactions, net	(443)	(211)	91
Other, net	(1)	(1)	(1)
Net cash provided by (used in) financing activities	(677)	3,663	2,683
Change in cash, cash equivalents and restricted cash	465	1,427	(587)
Cash, cash equivalents and restricted cash, beginning of year	4,592	3,165	3,752
Cash, cash equivalents and restricted cash, end of year	5,057	4,592	3,165
Supplemental disclosures of cash flow information
Net cash paid (received) for interest	67	67	71
Net cash paid (received) for income tax	(35)	0	0
Non-cash transactions:
Transfer of mortgage loans to affiliates	43	0	0
Transfer of limited partnerships and limited liability companies from affiliates	$ 43	$ 0	$ 0